Ad is loading...
DBIWX
Price
$10.28
Change
+$0.03 (+0.29%)
Updated
Nov 22 closing price
PASCX
Price
$11.10
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
Ad is loading...

DBIWX vs PASCX

Header iconDBIWX vs PASCX Comparison
Open Charts DBIWX vs PASCXBanner chart's image
DWS Global Macro R6
Price$10.28
Change+$0.03 (+0.29%)
VolumeN/A
CapitalizationN/A
PIMCO All Asset C
Price$11.10
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
DBIWX vs PASCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DBIWX vs. PASCX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DBIWX is a StrongBuy and PASCX is a Hold.

FUNDAMENTALS
Fundamentals
PASCX has more cash in the bank: 12B vs. DBIWX (170M). PASCX pays higher dividends than DBIWX: PASCX (2.69) vs DBIWX (1.76). DBIWX was incepted earlier than PASCX: DBIWX (5 years) vs PASCX (22 years). PASCX is a more actively managed with annual turnover of: 73.00 vs. DBIWX (48.00). DBIWX has a lower initial minimum investment than PASCX: DBIWX (0) vs PASCX (1000). PASCX annual gain was more profitable for investors over the last year : 8.87 vs. DBIWX (7.62). PASCX return over 5 years is better than : 21.82 vs. DBIWX (15.20).
DBIWXPASCXDBIWX / PASCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence5 years22 years-
Gain YTD4.2433.792112%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets170M12B1%
Annual Yield % from dividends1.762.6965%
Returns for 1 year7.628.8786%
Returns for 3 years5.56-1.53-364%
Returns for 5 years15.2021.8270%
Returns for 10 yearsN/A35.90-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RETO0.910.04
+4.01%
ReTo Eco-Solutions
SWKS85.051.62
+1.94%
Skyworks Solutions
NFGC1.62-0.03
-1.82%
New Found Gold Corp
SWTX36.30-1.14
-3.04%
SpringWorks Therapeutics
BZUN2.38-0.21
-8.11%
Baozun